NCT05407181

Brief Summary

Liver dysfunction marked by elevated alanine transaminase enzymes is quite common in dengue patients and subsequently affects the disease's severity and healing process. Unfortunately, liver function tests cannot always be done, especially in hospitals with limited facilities. In contrast, routine hematology tests are considered regular and inexpensive tests that can be performed on dengue patients. Therefore, this study aims to determine hematological parameters as markers of elevated liver enzymes in dengue patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
11

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

June 3, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 3, 2022

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 7, 2022

Completed
Last Updated

June 7, 2022

Status Verified

June 1, 2022

Enrollment Period

Same day

First QC Date

June 1, 2022

Last Update Submit

June 1, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Correlation of SGPT/ALT with Lymphocytes

    Correlation of SGPT/ALT with Lymphocytes

    May 30-June 5 2022

  • Correlation of SGPT/ALT with HFLC

    Correlation of SGPT/ALT with HFLC

    May 30-June 5 2022

Interventions

Data was collected through routine blood and liver function tests using a hematology analyzer and ELISA, respectively.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study is a cross-sectional study involving 11 dengue fever patients, consisting of 9 men and 2 women at Sebelas Maret University Hospital (RS UNS), Sukoharjo.

You may qualify if:

  • patients who were hospitalized at UNS Hospital with the following criteria: (1) adult patients (19-65 years); (2) diagnosed with dengue hemorrhagic fever according to WHO 2011 criteria; (3) routine blood examination at least once in seven days since the onset of fever; and (4) checked alanine transaminase and aspartate transaminase levels at least once in seven days from the onset of fever.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

RS UNS (Universitas Sebelas Maret Hospital)

Sukoharjo, Central Java, 57161, Indonesia

RECRUITING

Universitas Sebelas Maret Hospital

Sukoharjo, Central Java, 57161, Indonesia

RECRUITING

MeSH Terms

Conditions

Dengue

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Mosquito-Borne DiseasesVector Borne DiseasesInfectionsArbovirus InfectionsVirus DiseasesFlavivirus InfectionsFlaviviridae InfectionsRNA Virus InfectionsHemorrhagic Fevers, Viral

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Nurhasan Agung Prabowo, MD

    Universitas Sebelas Maret

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nurhasan Agung Prabowo, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
dr. Nurhasan Agung Prabowo, Sp.PD

Study Record Dates

First Submitted

June 1, 2022

First Posted

June 7, 2022

Study Start

June 3, 2022

Primary Completion

June 3, 2022

Study Completion

June 5, 2022

Last Updated

June 7, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations